Immunic, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $138.0M | $95.7M |
| Jun 2022 | — | $127.8M | $88.1M |
| Sep 2022 | — | $108.8M | $72.8M |
| Dec 2022 | — | $113.7M | $106.7M |
| Mar 2023 | — | $91.2M | $92.8M |
| Jun 2023 | — | $69.3M | $77.3M |
| Sep 2023 | — | $48.4M | $59.7M |
| Dec 2023 | — | $28.9M | $46.7M |
| Mar 2024 | — | $83.6M | $97.3M |
| Jun 2024 | — | $63.6M | $79.7M |
| Sep 2024 | — | $41.2M | $59.1M |
| Dec 2024 | — | $18.4M | $35.7M |
| Mar 2025 | — | $-5.3M | $14.3M |
| Jun 2025 | — | $33.9M | $55.3M |
| Sep 2025 | — | $10.5M | $35.1M |
| Dec 2025 | — | $-6.7M | $15.5M |
| Mar 2026 | — | $151.2M | $186.6M |
| Jun 2026 | — | $127.6M | $155.1M |